Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)
Source: SeekingAlpha
2025-10-07 23:57:48 ET
Topline Summary and Update
Read the full article on Seeking Alpha
For further details see:
Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)
Verastem Inc.
NASDAQ: VSTM
VSTM Trading
2.37% G/L:
$5.83 Last:
570,987 Volume:
$5.74 Open:
VSTM Latest News
March 17, 2026 06:03:00 pm
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
VSTM Stock Data
$424,027,638
66,108,246
1.4%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Needham
